Green Alpha Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $863K | Buy |
31,271
+2,597
| +9% | +$71.7K | 0.82% | 41 |
|
|
2025
Q1 | $813K | Buy |
28,674
+11,774
| +70% | +$334K | 0.87% | 34 |
|
|
2024
Q4 | $703K | Buy |
16,900
+5,987
| +55% | +$249K | 0.56% | 61 |
|
|
2024
Q3 | $729K | Buy |
10,913
+637
| +6% | +$42.6K | 0.57% | 64 |
|
|
2024
Q2 | $1.22M | Sell |
10,276
-2,676
| -21% | -$318K | 0.98% | 33 |
|
|
2024
Q1 | $1.38M | Buy |
12,952
+1,354
| +12% | +$144K | 1% | 32 |
|
|
2023
Q4 | $1.15M | Sell |
11,598
-133
| -1% | -$13.2K | 0.83% | 37 |
|
|
2023
Q3 | $1.21M | Buy |
11,731
+622
| +6% | +$64.2K | 0.93% | 36 |
|
|
2023
Q2 | $1.35M | Buy |
11,109
+1,311
| +13% | +$159K | 0.89% | 41 |
|
|
2023
Q1 | $1.5M | Sell |
9,798
-741
| -7% | -$114K | 1.06% | 28 |
|
|
2022
Q4 | $1.89M | Buy |
10,539
+1,604
| +18% | +$288K | 1.57% | 8 |
|
|
2022
Q3 | $1.06M | Sell |
8,935
-77,650
| -90% | -$9.19M | 0.9% | 35 |
|
|
2022
Q2 | $12.4M | Buy |
86,585
+78,801
| +1,012% | +$11.3M | 2.84% | 8 |
|
|
2022
Q1 | $1.34M | Buy |
7,784
+721
| +10% | +$124K | 0.9% | 42 |
|
|
2021
Q4 | $1.79M | Buy |
7,063
+326
| +5% | +$82.8K | 1.21% | 24 |
|
|
2021
Q3 | $2.59M | Sell |
6,737
-885
| -12% | -$341K | 1.79% | 3 |
|
|
2021
Q2 | $1.79M | Sell |
7,622
-4,998
| -40% | -$1.17M | 1.22% | 19 |
|
|
2021
Q1 | $1.65M | Sell |
12,620
-1,944
| -13% | -$255K | 1.64% | 14 |
|
|
2020
Q4 | $1.52M | Buy |
+14,564
| New | +$1.52M | 1.84% | 14 |
|